The immunomodulatory drug Leflunomide inhibits cell cycle progression of B-CLL cells [3]

  • I. Ringshausen
  • , M. Oelsner
  • , C. Bogner
  • , C. Peschel
  • , T. Decker

Research output: Contribution to journalLetterpeer-review

51 Scopus citations
Original languageEnglish
Pages (from-to)635-638
Number of pages4
JournalLeukemia
Volume22
Issue number3
DOIs
StatePublished - Mar 2008

Cite this